Rapid test for malaria

Embed Size (px)

Citation preview

  • 8/8/2019 Rapid test for malaria

    1/20

  • 8/8/2019 Rapid test for malaria

    2/20

    INTRODUCTION

    MALARIA INFECTION

    life-threatening disease caused by parasites ofthespeciesPlasmodium

    infectious

    preventableand curable prevention: prophylactic antibiotic, doxycycline

    treatment:combination of drugs knownasartemisinin-based

    combinationtherapies (ACTs)

    MOT:Bite ofinfected vectormosquito, female Anophelesminimus flavirotris

  • 8/8/2019 Rapid test for malaria

    3/20

    SpeciesofPlasmodiumparasites: Can infect humans:

    P. falciparum P.vivax

    P.ovale P.malariae

    INTRODUCTION

    P. falciparum isthemost deadly.

    P. falciparum and P. vivax arethemost prevalent.

    Female Anophelesminimus flavirostris

  • 8/8/2019 Rapid test for malaria

    4/20

    INTRODUCTION

    Symptoms:first commonsymptoms whichusually appear10 to15 daysaftera personisinfected.

    fever headache

    chills vomiting

  • 8/8/2019 Rapid test for malaria

    5/20

    INTRODUCTION

    Ofutmostimportanceforbetterpatientmanagementand speedy recovery are:

    Early detection

    - Cerebralmalarialand drugresistanceassociated withfalciparum

    malaria- Morbidity

    Early differentiation

    - course oftreatmentis dependent onthespecies

  • 8/8/2019 Rapid test for malaria

    6/20

    DIAGNOSTIC TESTS

    Blood Smear Gold standard

    Rapid TestforMalaria Pan + Pv + Pf

    FirstSign ParaView-3

    Isarapid self-performing,qualitative, two sitesandwichimmunoassayutilizingwhole blood

  • 8/8/2019 Rapid test for malaria

    7/20

    DIAGNOSTIC TESTS

    Rapid Test for Malaria Pan + Pv + PfFirstSign ParaView-3

    PARASITE DETECTION OF

    P. falciparum P. falciparum specific histidine richprotein-2 (Pf. HRP-2)

    P. vivax P. vivax specific parasitelactate dehydrogenase (pLDH)

    P. ovale and P. malaria Panmalariaspecific parasite

    lactate dehydrogenase(pLDH)

    Detectionsystemis based on:

  • 8/8/2019 Rapid test for malaria

    8/20

    isa watersoluble protein expressed onthered cellmembranesurface produced by theasexualstagesand gametocytes ofP.

    falciparum

    shownto remaininthe blood foratleast28 daysaftertheinitiation ofantimalarial therapy

    solubleglycolytic enzyme produced by theasexualand sexualstages ofthelive

    parasites itis presentinand released fromthe parasiteinfected

    erythrocytes. Ithas beenfound inall 4 humanmalariaspecies, and differentisomers of pLDH foreach ofthe 4speciesexist

  • 8/8/2019 Rapid test for malaria

    9/20

    PRINCIPLE

    Immunochromatographic assay

    -colloidalgold conjugate ofanti-HRP-2antibody,antiP. Vivax specific pLDH antibody and anti PanspecificpLDH antibody complexes HRP-2/corresponding pLDH

    inthelysed sample.

    -unreacted conjugatesalong withtherabbitantiseracolloidalgold conjugateand unbound complex(ifany),movesfurtheronthemebrane and are

    subsequently immobilized by anti-rabbitantibodiescoated onthemembraneatthemembraneatthecontrolregion

  • 8/8/2019 Rapid test for malaria

    10/20

    PRINCIPLE

  • 8/8/2019 Rapid test for malaria

    11/20

    ANTIBODY AND ANTIGEN

    ANTIBODY ANTIGEN

    Monoclonalanti Pf.- HRP2antibody

    monoclonalantiP.vivaxspecific pLDH antibody

    monoclonalanti panspecific pLDH antibody

    anti-rabbitantibody(control)

    Pf. HRP2

    P.vivax

    Pan

  • 8/8/2019 Rapid test for malaria

    12/20

    REAGENTS AND

    MATERIALS USED1. TEST DEVICE:

    Containsmembrane assembly

    pre-dispensed with:

    monoclonalanti- Pf. HRP2antibody-colloidalgold conjugate

    monoclonalanti P.vivax specific pLDHantibody-colloidalgold conjugate

    monoclonalanti panspecific pLDHantibody-colloidalgold conjugate

    Rabbitglobulin colloidalgold conjugate

    2. DESSICANT POUCH3. 5l SAMPLE LOOP

    4. CLEARING BUFFER IN A DROPPER BOTTLE

    5. PACKAGE INSERT

  • 8/8/2019 Rapid test for malaria

    13/20

    DESCRIPTIONS OF THE TEST

    Canspecifically detectand differentiate Pf & Pv-which constituteabout 90% ofthetotalmalaria occurrence

    globally.

    Good clinicalsensitivity and specificity >98% forP.falciparum malariae-dueto HRP-2 based detection.

    Ableto monitorsuccess ofanti-malarialtherapy-through Pan band.

  • 8/8/2019 Rapid test for malaria

    14/20

    LIMITATIONS OF THE TEST

    Cannotspecifically detectand differentiateP.malariae andP.ovale.

    HRP-2 isnotsecreted ingametogony stage. Hence,in carriers, the HRP-2may beabsent.

  • 8/8/2019 Rapid test for malaria

    15/20

  • 8/8/2019 Rapid test for malaria

    16/20

    PROCEDURES

  • 8/8/2019 Rapid test for malaria

    17/20

  • 8/8/2019 Rapid test for malaria

    18/20

    INTERPRETATION OF RESULTS

  • 8/8/2019 Rapid test for malaria

    19/20

    INTERPRETATION OF RESULTS

    Negative (-)A negativeresultindicatestheabsence ofany malarialparasiteinthesample

    Positive (+):

    A positiveresult onthe Pfregionindicatesthe presence ofP. falciparum infection

    A positiveresult onthe Pvregionindicatesthe presence ofP.vivax infection

    A positiveresult onthe Panregion butanegativeresult oneitherPfand Pvregionsindicatetheinfection of othermalarial parasitespecies ( P.malariae and P.ovale).

    A positiveresult onalltheregionsindicateamixed malarial

    parasiteinfection

  • 8/8/2019 Rapid test for malaria

    20/20

    MANNER OF REPORTING

    Negative (-)Only one pink/pink-purple band appearsatthe controlregionC

    Positive (+):

    1. P. falciparum malariaInadditionto the control band, a pink/purple band appearsat

    the Pfand Panregionsrespectively

    2. P. vivax malariaInadditionto the control band, a pink/purple band appearsat

    Pvand Panregionsrespectively

    3. OtherspeciesInadditionto the control band, one pink/purple band appears

    only atthe Panregion

    4. Mixed infectionInadditionto the control band, a pink/purple band appearsat

    Pf, Pvand Panregions